Bailard’s Surmodics SRDX Stock Holding History

Bailard’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,123	Closed	-$257K	–	807
2024 Q2	$257K	Buy	+6,123	New	+$209K	0.01%	595

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bailard's SRDX Position: Q3 2024 in Review

Bailard sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 6,123 shares — an estimated $257K sold.

Bailard first reported a position in SRDX in Q2 2024 and held it in 1 quarter. The position peaked at $257K in Q2 2024. 126 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.

Bailard reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
Bailard sold 6,123 Surmodics shares in Q3 2024, an estimated $257K.
Bailard first reported a position in Surmodics in Q2 2024 and held it in 1 quarter.
Bailard's Surmodics position peaked at $257K in Q2 2024.
126 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.

Based on Bailard's 13F filing for Q3 2024, filed 30 Oct 2024.